Oral submucous fibrosis (OSF) is a chronic progressive, potentially malignant disorder involving the oral mucosa and occasionally the pharynx and upper third of the esophagus. It is characterized by juxta-epithelial hyalinization, fibrosis, epithelial atrophy, and stiffness of the oral mucosa causing limitation in mouth opening and difficulty in eating. 1,2 OSF is caused by chewing areca nut, which is the fourth most addictive substance (following alcohol, tobacco, and caffeine), with 600 million people, globally, consuming it. 3,4 It has a malignant transformation rate of 7%-13%. 5 Biomarkers reflecting the molecular changes in OSF have been studied, with the intent of understanding pathogenesis and identifying biomarkers of clinical relevance. Several molecular biomarkers of